Ticker Details
PMV Pharmaceuticals, Inc.
IPO Date:	September 25, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$55.34M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.44 | 3.37%
Avg Daily Range (30 D):	$0.03 | 2.85%
Avg Daily Range (90 D):	$0.03 | 2.69%

Institutional Daily Volume
Avg Daily Volume:	.42M
Avg Daily Volume (30 D):	.24M
Avg Daily Volume (90 D):	.33M

Trade Size
Avg Trade Size (Sh.):	109
Avg Trade Size (Sh.) (30 D):	226
Avg Trade Size (Sh.) (90 D):	254

Institutional Trades
Total Institutional Trades:	873
Avg Institutional Trade:	$2.32M
Avg Institutional Trade (30 D):	$1.52M
Avg Institutional Trade (90 D):	$1.52M
Avg Institutional Trade Volume:	.15M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.22M
Avg Closing Trade (30 D):	$6.87M
Avg Closing Trade (90 D):	$6.87M
Avg Closing Volume:	147.98K

News

Jun 3, 2024 @ 1:55 PM Here's Why PMV Pharmaceuticals (PMVP) Could be Gre... Source: Zacks Equity Research

May 29, 2024 @ 11:00 AM Foundation Medicine and PMV Pharma Announce Collab... Source: PMV Pharmaceuticals, Inc.

May 28, 2024 @ 1:47 PM Here's Why You Should Buy Acrivon Therapeutics (AC... Source: Zacks Equity Research

Mar 18, 2024 @ 8:01 PM PMV Pharmaceuticals PYNNACLE Phase I Data of Rezat... Source: PMV Pharmaceuticals, Inc.

Feb 29, 2024 @ 9:01 PM PMV Pharmaceuticals Reports Full Year 2023 Financi... Source: PMV Pharmaceuticals, Inc.

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS		$-.4	$-.41
Diluted EPS		$-.4	$-.41
Revenue		$1.48M	$1.69M
Gross Profit
Net Income / Loss		$-21.06M	$-21.21M
Operating Income / Loss		$-22.52M	$-22.88M
Cost of Revenue
Net Cash Flow		$-7.79M	$-7.21M
PE Ratio